FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Telithromycin (Ketek) Tablets
Status: Discontinuation
»Therapeutic Categories:

Expand all

Sanofi (New 03/11/2016)

Company Contact Information:
800-981-2491

Presentation Posting Date Related Information
Ketek® (telithromycin) Tablets 400 mg Tablets (NDC 0088-2225-41) N/A The permanent discontinuation of these drug products is the result of a business decision.
Ketek® (telithromycin) Tablets 300 mg Tablets (NDC 0088-2223-20) N/A The permanent discontinuation of these drug products is the result of a business decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English